Jephesson A. dos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jephesson A. dos Santos has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Giovana Ravizzoni Onzi
Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication - Guido Lenz
Labsinal, Departamento de Biofísica, Universidade Federal Do Rio Grande Do Sul (UFRGS), Rua Bento Gonçalves, 9500, Prédio 43431 - Lab. 115, Porto Alegre, RS, 91501-970, Brazil.
1 shared publication - Julieti Huch Buss
Universidade Federal do Rio Grande do Sul (UFRGS) 1 Departamento de Biofísica Porto Alegre, RS 91509-900 , Brazil
1 shared publication Karine R. Begnini
Departamento de Biofísica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
1 shared publicationLuana S. Lenz
Departamento de Biofísica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
1 shared publication
Latest Publications
- 1 January 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (1) , 3-11
The Origins of Phenotypic Heterogeneity in Cancer
Heterogeneity is a pervasive feature of cancer, and understanding the sources and regulatory mechanisms underlying heterogeneity could provide key insights to help improve the diagnosis and treatment of cancer. In this review, we discuss the origin of heterogeneity in the phenotype of individual cancer cells. Genotype–phenotype (G–P) maps are widely used in evolutionary biology to represent the complex interactions of genes and the environment that lead to phenotypes that impact fitness. Here, we present the rationale of an extended G–P (eG–P) map with a cone structure in cancer. The eG–P cone is formed by cells that are similar at the genome layer but gradually increase variability in the epigenome, transcriptome, proteome, metabolome, and signalome layers to produce large variability at the phenome layer. Experimental evidence from single-cell-omics analyses supporting the cancer eG–P cone concept is presented, and the impact of epimutations and the interaction of cancer and tumor microenvironmental eG–P cones are integrated with the current understanding of cancer biology. The eG–P cone concept uncovers potential therapeutic strategies to reduce cancer evolution and improve cancer treatment. More methods to study phenotypes in single cells will be the key to better understand cancer cell fitness in tumor biology and therapeutics.
- 1 January 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (1) , 3-11
The Origins of Phenotypic Heterogeneity in Cancer
Heterogeneity is a pervasive feature of cancer, and understanding the sources and regulatory mechanisms underlying heterogeneity could provide key insights to help improve the diagnosis and treatment of cancer. In this review, we discuss the origin of heterogeneity in the phenotype of individual cancer cells. Genotype–phenotype (G–P) maps are widely used in evolutionary biology to represent the complex interactions of genes and the environment that lead to phenotypes that impact fitness. Here, we present the rationale of an extended G–P (eG–P) map with a cone structure in cancer. The eG–P cone is formed by cells that are similar at the genome layer but gradually increase variability in the epigenome, transcriptome, proteome, metabolome, and signalome layers to produce large variability at the phenome layer. Experimental evidence from single-cell-omics analyses supporting the cancer eG–P cone concept is presented, and the impact of epimutations and the interaction of cancer and tumor microenvironmental eG–P cones are integrated with the current understanding of cancer biology. The eG–P cone concept uncovers potential therapeutic strategies to reduce cancer evolution and improve cancer treatment. More methods to study phenotypes in single cells will be the key to better understand cancer cell fitness in tumor biology and therapeutics.